Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-FTSE inches lower as 3i drop offsets Burberry surge

Thu, 14th Nov 2019 09:08

* FTSE 100 down 0.1%, FTSE 250 flat

* Burberry jumps after Q2 results

* 3i drops after H1 report

* FirstGroup tracking worst day in more than a year
(Adds news items, analyst comment, updates share prices)

By Shashwat Awasthi

Nov 14 (Reuters) - London's FTSE 100 edged lower on
Thursday, as a 6% drop in private equity company 3i and a
handful of stocks trading ex-dividend overshadowed an
earnings-driven surge in luxury brand Burberry.

The main index shed 0.1% with 3i Group hitting a
five-month low after its first-half report and heavyweight
components Sainsbury, Shell and GSK
weighing as they traded without dividend entitlement.

Luxury brand Burberry, however, surged 7% as the
popularity of designer Riccardo Tisci's collections boosted
quarterly sales and offset declines in Hong Kong where trading
was hit by ongoing protests.

The mid-cap FTSE 250 was flat, though transport
operator FirstGroup slid 14.5%, on track for its worst
day since May 2018 after a bigger first-half loss due to a
charge related to its Greyhound bus line business.

British markets avoided sharp declines despite a host of
trigger points, including weak Chinese factory output data,
anxiety around U.S.-China trade and political uncertainty in the
U.S. amid an impeachment inquiry against President Donald Trump.

Slowing Chinese factory output growth was yet another sign
of how Beijing's trade dispute with Washington was weighing on
demand. To that end, China said the countries were holding
in-depth discussions on a "phase one" trade agreement.

"If a deal doesn't go through in the next couple of weeks,
the optimism seen in financial markets will rapidly turn into
pessimism and I wouldn't be surprised to see a 5-10% correction
in equity markets," said Hussein Sayed, Chief Market Strategist
at FXTM.

"At this stage, markets are in a wait-and-see mode until
further developments emerge."

Mid-cap Tullow Oil, which tanked nearly 30% in the
previous session after cutting its production forecast, skidded
another 4.5% as multiple brokerages downgraded the stock.

Jefferies analysts said poor quality of crude that Tullow
discovered in Guyana was "an epic setback".

Airport operator Stobart tumbled as much as 9% on
the small-cap index after suspendeding its dividend and posting
a bigger first-half loss.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by
Shailesh Kuber, Bernard Orr)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.